Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel two-step synthesis of indole mono-substituted 2-hydroxy-3-(1H-indol-3-yl) propionic acid. Cost-effective route for IDO/TDO inhibitor intermediates.
Patent CN113135865B details a green, one-step synthesis avoiding toxic acrylamide. Discover cost-effective manufacturing and reliable supply chain solutions.
Novel liquid phase method for cyclic peptides using 2-MeTHF. Reduces environmental load and improves purity without column chromatography for reliable supply.
Patent CN113354521A reveals a one-step synthesis route for 2-methoxy-5-fluoro bromoacetophenone, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112300028B discloses a high-yield route for 2-amino-3-methoxy-5-bromoxynil avoiding hazardous KMnO4. Delivers cost reduction and supply stability for API manufacturing.
Patent CN115850188A reveals a high-yield synthesis for benzimidazole intermediates used in electronic polyimides, offering superior purity and scalable manufacturing capabilities.
Patent CN110606855B reveals a novel Cu-catalyzed synthesis for benzothienoisoquinoline derivatives. Discover cost-effective, scalable manufacturing solutions for high-purity pharmaceutical intermediates.
Patent CN112608281A reveals a room-temperature synthesis of quinazolinones with high purity, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN121318899A details a novel resin-catalyzed route for 3-methyltetrahydropyran from BDO waste. This method offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN101698669B offers single-solvent GVNE synthesis. High yield, easy recovery, cost reduction for pharma intermediates.
Patent CN105348279B reveals optimized synthesis for Aclidinium bromide intermediates ensuring high purity and scalable supply chain reliability for global pharmaceutical manufacturers.
Patent CN1247539C details a high-yield route for chiral beta-lactams, offering simplified purification and industrial scalability for API manufacturers.
Patent CN1309121A details efficient chiral resolution of antihistamine intermediates using DPTTA, offering high purity and scalable manufacturing for global supply chains.
Patent CN1511826A introduces a robust ketone-based route for beta-amino acids, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global pharma.
Patent CN1314691C reveals a novel one-pot synthesis for Faropenem Sodium from 4-AA. Discover cost-effective manufacturing strategies and high-purity supply solutions.
Patent CN104496981B reveals a high-yield route for COPD drug intermediates. Discover cost-effective manufacturing and scalable supply chain solutions for pharmaceutical production.
Advanced Brivaracetam synthesis patent CN106432030A offers high optical purity without heavy metals. Reliable supplier for cost-effective pharmaceutical intermediate manufacturing.
Patent CN1786179A details a novel dual-enzyme biocatalytic route for S-(+)-2,2-dimethylcyclopropylcarboxamide, offering superior stereocontrol and reduced environmental impact for cilastatin synthesis.
Novel acid-catalyzed route offers high yield and cost efficiency for pharmaceutical intermediates manufacturing without precious metals.
Patent CN103467311B details a novel chiral cobalt complex synthesis. This technology offers a simplified one-step route for catalytic applications, ensuring supply chain stability and cost efficiency for global pharmaceutical manufacturers.